D. Hogan

发表

Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.

T. DeFrancesco, B. Keene, C. Atkins, 2009, Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology.

Antiplatelet effects and pharmacodynamics of clopidogrel in cats.

M. Ward, D. Hogan, H. Green, 2004, Journal of the American Veterinary Medical Association.

Use of n-butyl cyanoacrylate to reduce left to right shunting of an abdominal arteriovenous malformation in a dog.

M. Hogan, D. Hogan, C. K. Lim, 2017, Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology.

Feline Cardiogenic Arterial Thromboembolism: Prevention and Therapy.

D. Hogan, 2017, The Veterinary clinics of North America. Small animal practice.

Chapter 35 – Treatment and Prevention of Feline Arterial Thromboembolism

D. Hogan, 2016 .

Secondary prevention of cardiogenic arterial thromboembolism in the cat: The double-blind, randomized, positive-controlled feline arterial thromboembolism; clopidogrel vs. aspirin trial (FAT CAT).

H. Weng, B. Keene, P. Fox, 2015, Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology.

Cardiogenic embolism in the cat.

B. Brainard, D. Hogan, 2015, Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology.

Prevention and Management of Thromboembolism

D. Hogan, 2006 .

Comparison of metabolomics and platelet aggregometry between Plavix and generic clopidogrel in cats: a pilot study

G. Moore, Pamela M Lee, D. Hogan, 2018, Journal of feline medicine and surgery.

Multicenter evaluation of plasma N-terminal probrain natriuretic peptide (NT-pro BNP) as a biochemical screening test for asymptomatic (occult) cardiomyopathy in cats.

T. DeFrancesco, B. Keene, C. Atkins, 2011, Journal of veterinary internal medicine.

LUNG VOLUME REDUCTION (LVR) BY BRONCHOSCOPIC THERMAL VAPOR ABLATION (BTVA)

E. Swenson, M. Emery, D. Hogan, 2007 .

International collaborative study to assess cardiovascular risk and evaluate long‐term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study

A. Motsinger-Reif, K. Lamb, R. Santilli, 2018, Journal of veterinary internal medicine.

International collaborative study to assess cardiovascular risk and evaluate long‐term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study

C. Bové, A. Motsinger-Reif, D. Ohad, 2018, Journal of veterinary internal medicine.

International collaborative study to assess cardiovascular risk and evaluate long‐term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study

C. Bové, A. Motsinger-Reif, D. Ohad, 2018, Journal of veterinary internal medicine.

Chapter 169 – Thrombolytic Agents

D. Hogan, 2015 .

Antithrombotic effect of enoxaparin in clinically healthy cats: a venous stasis model.

C. V. Wiele, D. Hogan, H. Green, 2010, Journal of veterinary internal medicine.

In vitro effects of the glycoprotein IIb/IIIa receptor antagonists abciximab and eptifibatide on platelet aggregation in healthy cats.

J. Durham, D. Hogan, Aliya N Magee, 2014, American journal of veterinary research.

Evaluation of antiplatelet effects of ticlopidine in cats.

M. Ward, D. Hogan, H. Green, 2004, American journal of veterinary research.

Suspected iatrogenic paradoxical embolization in a cat.

D. Hogan, H. Green, 2005, Journal of the American Animal Hospital Association.

Perceptions of quality of life and priorities of owners of cats with heart disease.

D. C. Brown, C. Reynolds, M. Oyama, 2010, Journal of veterinary internal medicine.

Effect of clopidogrel on tissue-plasminogen activator-induced in vitro thrombolysis of feline whole blood thrombi.

M. Ward, D. Hogan, 2004, American journal of veterinary research.

Intravascular occlusion for the correction of extrahepatic portosystemic shunts in dogs.

D. Hogan, H. Green, N. Parnell, 2010, Journal of veterinary internal medicine.

Intravascular O cclusion f or the C orrection of E xtrahepatic Portosystemic Shunts i n Dogs

D. Hogan, 2010 .

Paraneoplastic thrombocytosis-induced systemic thromboembolism in a cat.

D. Sisson, B. Kitchell, D. Hogan, 1999, Journal of the American Animal Hospital Association.

Treatment of acute epistaxis secondary to guttural pouch mycosis with transarterial nitinol vascular occlusion plugs in three equids.

J. Hawkins, D. Hogan, Kira C Delfs, 2009, Journal of the American Veterinary Medical Association.

Treatment of Hemorrhage Associated with Guttural Pouch Mycosis

D. Hogan, 2014 .

Dose determination of fondaparinux in healthy cats.

T. Whittem, D. Hogan, H. Green, 2012, American journal of veterinary research.

In vitro effects of lipid emulsion on platelet function and thromboelastography in canine blood samples.

D. Hogan, N. Parnell, Laura Tonkin, 2013, American journal of veterinary research.

In vitro evaluation of the effect of hypothermia on coagulation in dogs via thromboelastography.

B. Austin, D. Hogan, Eric C. Hans, 2012, Journal of veterinary emergency and critical care.

Hypoxemia during outpatient gastrointestinal endoscopy: the effects of sedation and supplemental oxygen.

N. Keeling, D. Hogan, R. Kirkham, 1995, Journal of clinical anesthesia.

Chapter 188 – Thrombolytic Agents

D. Hogan, 2009 .

Identification of low and high frequency ranges for heart rate variability and blood pressure variability analyses using pharmacological autonomic blockade with atropine and propranolol in swine

D. Lay, A. Janczak, J. Marchant-Forde, 2011, Physiology & Behavior.

Transarterial correction of patent ductus arteriosus in small dogs with the Amplatz™ Vascular Plug 4: A pilot study.

D. Hogan, G. T. Goldfeder, G. Goldfeder, 2021, Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology.

Transarterial coil embolization of patent ductus arteriosus in small dogs with 0.025-inch vascular occlusion coils: 10 cases.

Matthew W. Miller, S. Gordon, D. Hogan, 2004, Journal of veterinary internal medicine.

Transarterial Coil Embolization of Patent Ductus Arteriosus in Small Dogs with 0.025‐Inch Vascular Occlusion Coils: 10 Cases

Matthew W. Miller, S. Gordon, D. Hogan, 2004 .

Safety of Transesophageal Pacing for 24 Hours in a Canine Model

J. Ramos-Vara, R. Sanders, D. Hogan, 2009, Pacing and clinical electrophysiology : PACE.

Thrombolytic Therapy in Dogs and Cats

J. C. Scott-Moncrieff, D. Hogan, Diplomate Acvim, 2001 .

Cranial vena caval syndrome secondary to transvenous pacemaker implantation in two dogs.

D. Hogan, H. Green, N. Parnell, 2008, Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology.

Transcatheter closure of patent ductus arteriosus in a dog with a peripheral vascular occlusion device.

R. Sanders, D. Hogan, H. Green, 2006, Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology.

Efficacy of transesophageal and transgastric cardiac pacing in the dog.

R. Sanders, D. Hogan, H. Green, 2010, Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology.

Use of transesophageal atrial pacing to provide temporary chronotropic support in a dog undergoing permanent pacemaker implantation.

R. Sanders, D. Hogan, H. Green, 2011, Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology.

Long‐term incidence and risk of noncardiovascular and all‐cause mortality in apparently healthy cats and cats with preclinical hypertrophic cardiomyopathy

C. Bové, A. Motsinger-Reif, D. Ohad, 2019, Journal of veterinary internal medicine.

Total anomalous pulmonary venous drainage in a dog.

W. V. Van Alstine, D. Hogan, H. Green, 2002, Journal of Veterinary Internal Medicine.